CT
Caradon Therapeutics, Inc.
SEC filingBiotechnology · Encinitas, CA
Amount raised$559Ksold at filing
Total offering$900K$341K still open
Investors in the raise7count reported to the SEC
FiledFeb 3, 2026first sale Jan 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Brian Laurence JohnsonExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.